Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks

202285 citationsJournal Article

Authors

gov; Unique identifier: NCT04349072.

Good health and well-being

Published in: Circulation

Volume 147, Issue 11, pp. 850-863

Field-Weighted Citation Impact: 13.62